From the New York Times Business Section, Tuesday January 14th:
“With its stock price low, Monsanto is considered a takeover target. Charles Benbrook, an agricultural biotechnology consultant in Sandpoint, Idaho, said he had been approached by two investment banks that were exploring whether Monsanto could be bought and sold off in pieces. ‘The whole issue is what the Roundup and herbicide-tolerant franchise is worth,’ said Dr. Benbrook, who has been a critic of Monsanto. And that, he said, depends on how long Roundup herbicide remains effective against weeds.”
